Researchers also associate ending GLP-1 therapy before pregnancy with a few risks.* Women who stopped taking a GLP-1 RA before or during early pregnancy had roughly 1.3x the risk of preterm birth, gestational diabetes, and high blood pressure conditions during pregnancy, compared to similar women who had not taken a GLP-1 RA
In most cases, small and repeatable habits are easier to maintain long-term
Wu is truly an artist
Tirzepatide, marketed as Zepbound for weight management, has shown higher average weight loss than semaglutide in many trial comparisons
Fat: focus on quality, not quantity Fat makes up the majority of calories on keto, but the "eat all the fat" approach common in some keto communities requires modification when semaglutide is slowing gastric emptying
Retatrutide + MOTS-c Dosing Protocol & Schedule Evidence-level notice No clinical trial has tested retatrutide + MOTS-c together